Coloplast A/S

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 08:10:29 10/06/2024 pm IST			5-day change	1st Jan Change
833.4 ^DKK	-0.88%		+3.22%	+7.90%

06/06	Transcript : Coloplast A/S - Analyst/Investor Day
15/05	COLOPLAST : Multiple silver linings in spite of a soft Q2 24

Coloplast A/S Provides Earnings Guidance for the Full Year of 2022

May 05, 2022 at 03:35 pm IST

Coloplast A/S provided earnings guidance for the full year of 2022. For the year, the company expects sales growth of around 15% and EBIT margin before special items of around 31%.

Latest news about Coloplast A/S

Transcript : Coloplast A/S - Analyst/Investor Day	06/06
COLOPLAST : Multiple silver linings in spite of a soft Q2 24	15/05
European shares hit one-month high as earnings take centre stage	07/05	RE
U.S. Futures Flat, European Stocks Rise	07/05	DJ
European shares hit one-month high on upbeat earnings, rate-cut optimism	07/05	RE
Transcript : Coloplast A/S, H1 2024 Earnings Call, May 07, 2024	07/05
Coloplast Posts Higher Fiscal H1 Net Profit, Revenue	07/05	MT
Coloplast Strengthens Ostomy Care Portfolio with Three Significant Product Launches	07/05	CI
Coloplast A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	07/05	CI
Coloplast A/S Revises Earnings Guidance for the Fiscal Year 2023/24	07/05	CI
Coloplast A/S Announces Interim Dividend for the First Half of 2023/24, Payable on May 15, 2024	07/05	CI
Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024.	27/02	CI
COLOPLAST : Q1 24: Many more positives beyond the margin beat	14/02
Nordic Shares Moved Upward Friday; Kongsberg Gruppen Topped Leaders	09/02	DJ
Global markets live: Tesco, Boeing, Roche, Exxon Mobil, PepsiCo...	09/02
Transcript : Coloplast A/S, Q1 2024 Earnings Call, Feb 09, 2024	09/02
European shares flat as higher yields counter earnings bump	09/02	RE
European shares inch up on earnings bump, higher yields weigh	09/02	RE
Coloplast Posts Growth in Fiscal Q1 Net Profit, Revenue	09/02	MT
Coloplast Launches Peristeen Light for People with Bowel Disorders	09/02	CI
Coloplast A/S Reports Earnings Results for the First Quarter Ended December 31, 2023	09/02	CI
Coloplast A/S Reaffirms Earnings Guidance for the Fiscal Year 2023/24	09/02	CI
Coloplast Rolls Out New Silicone Foam for Wound Care in US	31/01	MT
Coloplast A/SLaunches Biatain® Silicone Fit for Pressure Injury Prevention and Wound Management in the US	31/01	CI
Nordic Stocks Decreased Wednesday; Kone B Posted Biggest Loss	17/01	DJ

Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

20/08/2024 - Q3 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

COLOPLAST : Multiple silver linings in spite of a soft Q2 24

May 15, 2024 at 04:04 pm IST

More Strategies

Ratings for Coloplast A/S

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

840.8 DKK

Average target price

907.3 DKK

Spread / Average Target

+7.90%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
COLOPLAST A/S	+7.90%	27.39B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-41.00%	2.63B
HARTALEGA HOLDINGS	+26.30%	2.48B
WINNER MEDICAL CO., LTD.	-23.19%	2.31B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+5.99%	2.21B
TOP GLOVE CORPORATION BHD.	+24.44%	1.91B
KOSSAN RUBBER INDUSTRIES	+33.51%	1.34B
GVS S.P.A.	+27.89%	1.32B
NAKANISHI INC.	+1.64%	1.25B
RIVERSTONE HOLDINGS LIMITED	+31.91%	1.04B

Medical Supplies

Coloplast A/S

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Coloplast A/S Provides Earnings Guidance for the Full Year of 2022

Latest news about Coloplast A/S

Chart Coloplast A/S

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Coloplast A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Supplies